Balanced news tone
News Sentiment
NSIS-B sentiment intelligence
Novozymes A/S news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
72/100 classification confidence.
directly relevant articles
high-authority source matches
-0.1% over one week, +7.7% over four weeks, trend active, and near fair-value range.
Novozymes (CPSE:NSIS B) Stock Could Be 31% Below Fair Value After UndoAge Deal
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Novozymes (CPSE:NSIS B) Stock Could Be 31% Below Fair Value After UndoAge Deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 22 Jun 2026 07:00
- Source
- simplywall.st
A Look At Novozymes (CPSE:NSIS B) Valuation After Recent Share Price Weakness
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 May 2026 07:00
- Source
- Market source
Novozymes and Chr. Hansen Complete Merger, Forming Novonesis
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 29 Jan 2024 08:00
- Source
- European Biotechnology Magazine
Novozymes Agrees to Buy Chr. Hansen in $12.3 Billion Deal
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 12 Dec 2022 08:00
- Source
- Bloomberg.com